Lipid-lowering agents and the risk of hip fracture in a Medicaid population

Injury Prevention

Volumn 8, Issue 4, 2002, Pages 276-279

  Ray, Wayne A ^a   Daugherty, J R ^a   Griffin, M R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HIP FRACTURE; HUMAN; INCIDENCE; INFORMATION PROCESSING; MALE; MEDICAID; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

AGED; COHORT STUDIES; DATA COLLECTION; FEMALE; HIP FRACTURES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MEDICAID; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TENNESSEE;

EID: 0142140614     PISSN: 13538047     EISSN: 14755785     Source Type: Journal    
DOI: 10.1136/ip.8.4.276     Document Type: Article

References (20)

1. Ray WA. Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 1992;12:386-96.
2. Melton LJ III. The second fifty years. Promoting health and preventing disability. In: Berg RL, Cassells JS, eds. Osteoporosis. Washington, DC: National Academy Press, 1990: 76-100.
3. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986;314:1676-86. (Pubitemid 16097845)
4. Wang PS, Solomon DH, Mogun H, et al. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000;283:3211-6. (Pubitemid 30422038)
5. Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl- coenzyme A reductase and risk of fracture among older women. Lancet 2000;355:2185-8. (Pubitemid 30394324)
6. Meier CR, Schlienger RG, Kraenzlin ME, et al. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000;283:3205-10. (Pubitemid 30422037)
7. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989;129:837-49. (Pubitemid 19094261)
8. Anonymous. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980;303:1038-41.
9. Ray WA, Griffin MR, Fought RL, et al. Identification of fractures from computerized Medicare files. J Clin Epidemiol 1992;45:703-14.
10. Mirvis DM, Chang CF, Hall CJ, et al. TennCare-health system reform for Tennessee. JAMA 1995;274:1235-41.
11. Thapa PB, Ray WA. Medications and falls and fall-related injuries in the elderly. In: Bronstein AM, Brandt T, Wollacott M, eds. Clinical aspects of balance and related gait disorders. London: Edward Arnold, 1994.
12. Tinetti ME. Prevention of falls and fall injuries in elderly persons: a research agenda. Prev Med 1994;23:756-62. (Pubitemid 24377903)
13. Tinetti ME, Doucette J, Claus E, et al. Risk factors for serious injury during falls by older persons in the community. J Am Geriatr Soc 1995;43:1214-21.
14. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9. (Pubitemid 26137972)
15. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5. (Pubitemid 26137973)
16. Petitti DB. Hormone replacement therapy and heart disease prevention. JAMA 1998;280:650-2.
17. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13. (Pubitemid 28502636)
18. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522-9. (Pubitemid 30650747)
19. Pedersen TR, Kjekshus J. Statin drugs and the risk of fracture. JAMA 2000;284:1921-2.
20. van Staa TP, Wegman S, de Vries F, et al. Use of statins and risk of fractures. JAMA 2001;285:1850-5. (Pubitemid 32289152)